Shruti Agrawal
About Shruti Agrawal
Shruti Agrawal is the Clinical Development Lead for Lung Cancer at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in clinical pharmacology and oncology.
Current Role at Bristol Myers Squibb
Shruti Agrawal is currently serving as the Clinical Development Lead for lung cancer at Bristol Myers Squibb in Princeton, New Jersey. In this role, she is responsible for overseeing the clinical development processes specific to lung cancer therapies, ensuring effective trial design, and coordinating with multiple stakeholders to drive the projects forward.
Previous Roles at Bristol Myers Squibb
Shruti Agrawal has held various significant positions at Bristol Myers Squibb, reflecting her extensive experience in clinical pharmacology and oncology. She served as the Clinical Program Lead for lung cancer from 2018 to 2020, followed by a stint as Director of the Oncology Clinical Development Lung Program from 2017 to 2018. Additionally, she has been the Director of Clinical Pharmacology and Pharmacometrics from 2015 to 2017 and the Associate Director for the same division from 2012 to 2015. Earlier in her career at the company, she worked as a Senior Research Investigator and Research Investigator in Clinical Pharmacology and Pharmacometrics from 2006 to 2012.
Academic Contributions and Teaching Roles
From 2012 to 2014, Shruti Agrawal served as an Adjunct Professor in the Department of Chemical and Biochemical Engineering at Rutgers, The State University of New Jersey. During her time there, she contributed to the academic community by teaching and mentoring students in the field of chemical and biochemical engineering.
Educational Background
Shruti Agrawal has a strong academic foundation in pharmaceutical sciences. She received her B.S. in Pharmacy from Amravati University. She then pursued advanced degrees at the National Institute of Pharmaceutical Education and Research, where she achieved an M.S. in Pharmaceutics and a Ph.D. in Clinical Pharmacokinetics. Her extensive education has equipped her with deep expertise in pharmacology and related fields.
Professional Achievements in Clinical Pharmacology
Throughout her career, Shruti Agrawal has made significant contributions to the field of clinical pharmacology. She led the clinical pharmacology efforts for the successful dose optimization of Opdivo, facilitating its expanded use in various indications. Additionally, she played a key role in the first successful Biologics License Application (BLA) filing for Opdivo, marking a major milestone in immuno-oncology. Shruti has also held leadership roles within clinical pharmacology societies and has been an invited speaker at international conferences.